Doctors' Molecular And Imaging Sciences Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 5.82 Cr
as on 13-12-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 1.60 Cr
as on 13-12-2024
- Revenue 27.01%
(FY 2021)
- Profit 35.28%
(FY 2021)
- Ebitda 424.10%
(FY 2021)
- Net Worth -24.02%
(FY 2021)
- Total Assets -8.38%
(FY 2021)
About Doctors' Molecular And Imaging Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.82 Cr.
The company currently has active open charges totaling ₹1.60 Cr.
Pradipta Rath, Pothinaicker Ramakrishnan, Kota Ramgopal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74900TN2015PTC102664
- Company No.
102664
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Oct 2015
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruchirappalli, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Doctors' Molecular And Imaging Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradipta Rath  | Managing Director | 23-Oct-2015 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pothinaicker Ramakrishnan | Nominee Director | 23-Oct-2015 | Current |
| Kota Ramgopal | Nominee Director | 23-Oct-2015 | Current |
| Gnanaraj Jayachandran | Nominee Director | 23-Oct-2015 | Current |
| Kattuputhur Srinivasan | Director | 23-Oct-2015 | Current |
Financial Performance of Doctors' Molecular And Imaging Sciences.
Doctors' Molecular And Imaging Sciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 27.01% increase. The company also saw a substantial improvement in profitability, with a 35.28% increase in profit. The company's net worth observed a substantial decline by a decrease of 24.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Doctors' Molecular And Imaging Sciences?
In 2021, Doctors' Molecular And Imaging Sciences had a promoter holding of 55.36% and a public holding of 44.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Multispeciality Lab Services Private LimitedActive 21 yearsPradipta Rath, Pothinaicker Ramakrishnan and 2 more are mutual person
- Trivikrama Medical Services Private LimitedActive 12 years 7 months
Kota Ramgopal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 27 Jan 2023 | ₹1.60 Cr | Open |
How Many Employees Work at Doctors' Molecular And Imaging Sciences?
Unlock and access historical data on people associated with Doctors' Molecular And Imaging Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Doctors' Molecular And Imaging Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Doctors' Molecular And Imaging Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
